Patients With Systemic Cancer Have Lower Ovarian Reserve and Require Higher Gonadotropin Doses for Fertility Preservation (FP)

Fertility and Sterility - Netherlands
doi 10.1016/j.fertnstert.2015.07.836
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Fertility Preservation for Cancer Patients

Expert Review of Obstetrics & Gynecology
2008English

Safety and Feasibility of Performing Two Consecutive Ovarian Stimulation Cycles With the Use of Letrozole-Gonadotropin Protocol for Fertility Preservation in Breast Cancer Patients

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2013English

Fertility Preservation (FP) Does Not Adversely Impact Long-Term Cancer Outcomes

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2016English

Female Fertility Preservation in Patients With Musculoskeletal Cancer

Romanian Journal of Orthopaedic Surgery and Traumatology
2018English

BRCA Mutation Breast Cancer Patients Show Equivalent Ovarian Reserve and Response to IVF Stimulation Compared to BRCA Negative Patients and Other Malignancies Undergoing Fertility Preservation

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2017English

Fertility Preservation Options in Pediatric and Adolescent Patients With Cancer

Cancer
Cancer ResearchOncology
2018English

Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate?

Oncologist
Cancer ResearchMedicineOncology
2015English

Fertility Preservation in Ovarian Tumours

ecancermedicalscience
Cancer ResearchOncology
2018English

Fertility Preservation for Pediatric and Adolescent Patients With Cancer: Medical and Ethical Considerations

Pediatrics
Child HealthPediatricsPerinatology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy